1. Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus. Issue 10 (23rd September 2015) Authors: Welcher, Andrew A.; Boedigheimer, Michael; Kivitz, Alan J.; Amoura, Zahir; Buyon, Jill; Rudinskaya, Alla; Latinis, Kevin; Chiu, Kit; Oliner, Kelly S.; Damore, Michael A.; Arnold, Gregory E.; Sohn, Winnie; Chirmule, Narendra; Goyal, Lovely; Banfield, Christopher; Chung, James B. Journal: Arthritis & rheumatology Issue: Volume 67:Issue 10(2015) Page Start: 2713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and Safety of PF‐06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate‐to‐Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Issue 10 (7th September 2020) Authors: Robinson, Michael F.; Damjanov, Nemanja; Stamenkovic, Bojana; Radunovic, Goran; Kivitz, Alan; Cox, Lori; Manukyan, Zorayr; Banfield, Christopher; Saunders, Michael; Chandra, Deepa; Vincent, Michael S.; Mancuso, Jessica; Peeva, Elena; Beebe, Jean S. Journal: Arthritis & rheumatology Issue: Volume 72:Issue 10(2020) Page Start: 1621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of topical brepocitinib for the treatment of mild‐to‐moderate atopic dermatitis: a phase IIb, randomized, double‐blind, vehicle‐controlled, dose‐ranging and parallel‐group study. (1st December 2022) Authors: Landis, Megan N.; Arya, Mark; Smith, Stacy; Draelos, Zoe; Usdan, Lisa; Tarabar, Sanela; Pradhan, Vivek; Aggarwal, Sudeepta; Banfield, Christopher; Peeva, Elena; Vincent, Michael S.; Sikirica, Vanja; Xenakis, Jason; Beebe, Jean S. Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of topical brepocitinib for the treatment of mild‐to‐moderate atopic dermatitis: a phase IIb, randomized, double‐blind, vehicle‐controlled, dose‐ranging and parallel‐group study. (23rd October 2022) Authors: Landis, Megan N.; Arya, Mark; Smith, Stacy; Draelos, Zoe; Usdan, Lisa; Tarabar, Sanela; Pradhan, Vivek; Aggarwal, Sudeepta; Banfield, Christopher; Peeva, Elena; Vincent, Michael S.; Sikirica, Vanja; Xenakis, Jason; Beebe, Jean S. Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluating the Role of Janus Kinase Pathways in Platelet Homeostasis Using a Systems Modeling Approach. (25th June 2019) Authors: Koride, Sarita; Nayak, Satyaprakash; Banfield, Christopher; Peterson, Mark C. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 7(2019) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of a Janus kinase 1 inhibitor, PF‐04965842, in healthy subjects: A phase 1, randomized, placebo‐controlled, dose‐escalation study. (24th May 2018) Authors: Peeva, Elena; Hodge, Martin R.; Kieras, Elizabeth; Vazquez, Michael L.; Goteti, Kosalaram; Tarabar, Sanela G.; Alvey, Christine W.; Banfield, Christopher Journal: British journal of clinical pharmacology Issue: Volume 84:Number 8(2018) Page Start: 1776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. First‐in‐human, randomized dose‐escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF‐06480605 in healthy subjects. Issue 4 (28th January 2020) Authors: Banfield, Christopher; Rudin, Dan; Bhattacharya, Indranil; Goteti, Kosalaram; Li, Gang; Hassan‐Zahraee, Mina; Brown, Lisa S.; Hung, Kenneth E.; Pawlak, Sylvester; Lepsy, Christopher Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 4(2020) Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Kinetic‐Pharmacodynamic Model of Platelet Time Course in Patients With Moderate‐to‐Severe Atopic Dermatitis Treated With Oral Janus Kinase 1 Inhibitor Abrocitinib. (22nd September 2020) Authors: Soto, Elena; Banfield, Christopher; Gupta, Pankaj; Peterson, Mark C. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 10(2020) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LC–MS/MS assay for N1-methylnicotinamide in humans, an endogenous probe for renal transporters. (11th May 2018) Authors: Luo, Lina; Kay, Jared; Zhang, Jenny; Holliman, Christopher L; Rodrigues, A David; Dowty, Martin; Banfield, Christopher; Ramanathan, Ragu Journal: Bioanalysis Issue: Volume 10:Number 9(2018) Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P190 - The effect of CYP2C9 and CYP2C19 genotype on the pharmacokinetics of PF 04965842, A JAK1 inhibitor in clinical development. (2020) Authors: Dowty, Martin; Yang, Xin; Lin, Jian; Bauman, Jonathan; Doran, Angela; Goosen, Theunis; Wood, Linda; Johnson, Jillian; Banfield, Christopher; Gupta, Pankaj; Malhotra, Bimal Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗